Axios TechnologyValley
Exclusive: OpenAI has acquired Orchestra Bio

OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios.
Read at Axios Technology ↗Related

LabsFairStress: A deeper evaluation of fairness in LLM decision-making Hugging Face Blog

EuropeDaytona hits $1B valuation with $60M Series B for AI agent cloud Tech.eu
ValleyAI startup Firefly secures $20M to make the physical world a safer place SiliconANGLE
ValleyAuxoAI raises over $20M to bring AI expertise to the enterprise and redesign how work gets done SiliconANGLE

SiliconChina’s tech giants drop $35 billion on export-compliant Nvidia RTX Pro 5500 workstation GPU orders to power AI ambitions, according to reports Tom's Hardware
